ZBH Stock Overview
Operates as a medical technology company worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Zimmer Biomet Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$92.17 |
| 52 Week High | US$116.71 |
| 52 Week Low | US$89.92 |
| Beta | 0.78 |
| 1 Month Change | -10.56% |
| 3 Month Change | -11.65% |
| 1 Year Change | -19.96% |
| 3 Year Change | -23.59% |
| 5 Year Change | -32.92% |
| Change since IPO | 209.71% |
Recent News & Updates
Zimmer Biomet Holdings (NYSE:ZBH) Shareholders Will Want The ROCE Trajectory To Continue
May 27
Some May Be Optimistic About Zimmer Biomet Holdings' (NYSE:ZBH) Earnings
May 12Zimmer Biomet: Stronger Cash Flows Needed Before The Stock Rebounds
May 06Recent updates
Zimmer Biomet Holdings (NYSE:ZBH) Shareholders Will Want The ROCE Trajectory To Continue
May 27Some May Be Optimistic About Zimmer Biomet Holdings' (NYSE:ZBH) Earnings
May 12Zimmer Biomet: Stronger Cash Flows Needed Before The Stock Rebounds
May 06An Intrinsic Calculation For Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Suggests It's 39% Undervalued
Apr 09Zimmer Biomet Holdings (NYSE:ZBH) Has Announced A Dividend Of $0.24
Mar 15Zimmer Biomet Holdings (NYSE:ZBH) Has Announced A Dividend Of $0.24
Mar 01Zimmer Biomet: Adding To The Growth Profile
Feb 07Investors Appear Satisfied With Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Prospects
Feb 06These 4 Measures Indicate That Zimmer Biomet Holdings (NYSE:ZBH) Is Using Debt Reasonably Well
Jan 10Zimmer Biomet: Back On Offense With Strong Cash Flow Outlook
Jan 05Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24
Dec 21At US$108, Is It Time To Put Zimmer Biomet Holdings, Inc. (NYSE:ZBH) On Your Watch List?
Dec 08Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality
Nov 07Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 02Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Not Quite Adding Up
Oct 03Zimmer Biomet: The Undervalued Titan Of Joint Replacements
Oct 02Zimmer Biomet Stock: Don't Jump In At The 52-Week Low
Sep 19We Like These Underlying Return On Capital Trends At Zimmer Biomet Holdings (NYSE:ZBH)
Sep 18Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24
Sep 02Zimmer Biomet Holdings (NYSE:ZBH) Seems To Use Debt Quite Sensibly
Aug 27Are Investors Undervaluing Zimmer Biomet Holdings, Inc. (NYSE:ZBH) By 45%?
Jul 15Investors Interested In Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Earnings
Jul 02Zimmer Biomet: Brighter Prospects In H2 2024
Jul 02Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24
Jun 19When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Jun 05Zimmer Biomet Holdings: Moving Along
May 17Zimmer Biomet: Weight Loss Drug Concerns Are Overblown
Feb 05Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy'
Jan 20Shareholder Returns
| ZBH | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -0.5% | 1.7% | 1.7% |
| 1Y | -20.0% | 9.3% | 11.5% |
Return vs Industry: ZBH underperformed the US Medical Equipment industry which returned 10% over the past year.
Return vs Market: ZBH underperformed the US Market which returned 12.5% over the past year.
Price Volatility
| ZBH volatility | |
|---|---|
| ZBH Average Weekly Movement | 5.0% |
| Medical Equipment Industry Average Movement | 9.2% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 4.1% |
Stable Share Price: ZBH has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ZBH's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1927 | 17,000 | Ivan Tornos | www.zimmerbiomet.com |
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products.
Zimmer Biomet Holdings, Inc. Fundamentals Summary
| ZBH fundamental statistics | |
|---|---|
| Market cap | US$18.47b |
| Earnings (TTM) | US$913.40m |
| Revenue (TTM) | US$7.70b |
Is ZBH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZBH income statement (TTM) | |
|---|---|
| Revenue | US$7.70b |
| Cost of Revenue | US$2.22b |
| Gross Profit | US$5.48b |
| Other Expenses | US$4.57b |
| Earnings | US$913.40m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.62 |
| Gross Margin | 71.20% |
| Net Profit Margin | 11.86% |
| Debt/Equity Ratio | 59.1% |
How did ZBH perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/30 12:10 |
| End of Day Share Price | 2025/05/30 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Zimmer Biomet Holdings, Inc. is covered by 63 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Stephan Gasteyger | Atlantic Equities LLP |
| Jeffrey Johnson | Baird |